GLP-1 medications change how much you eat, which makes what you eat matter more. These articles cover eating well on semaglutide and similar drugs, protecting muscle when appetite drops, and what is worth tracking along the way.
No GLP-1 is FDA-approved for prediabetes, yet trials show strong results. Here is what the labels, the studies, and diabetes guidelines say, and why insurers often say no.
Fiber can help with GLP-1 constipation, but adding too much too fast may make things worse. Here's how to increase fiber safely while on GLP-1.
GLP-1 medications rarely cause hypoglycemia alone. The risk increases when combined with insulin or sulfonylureas. Here's who should monitor closely.
The FDA approved the first oral GLP-1 pill in January 2026. Here's what people with diabetes and prediabetes need to know about blood sugar, CGM impact, cost, and how it compares to the injectable including Eli Lilly's orforglipron.
GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.
What to Eat, What to Avoid, and How to Eat Smart when using Ozempic, Wegovy, Mounjaro or Saxenda.
When appetite drops, every meal counts for more. SNAQ helps you keep an eye on protein and nutrients with quick photo logging.
